19-7478326-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080662.4(PEX11G):c.479C>T(p.Ala160Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,458,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080662.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PEX11G | NM_080662.4 | c.479C>T | p.Ala160Val | missense_variant | 4/5 | ENST00000221480.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PEX11G | ENST00000221480.6 | c.479C>T | p.Ala160Val | missense_variant | 4/5 | 1 | NM_080662.4 | P1 | |
PEX11G | ENST00000593942.5 | c.269C>T | p.Ala90Val | missense_variant | 6/7 | 5 | |||
PEX11G | ENST00000593547.1 | c.443C>T | p.Ala148Val | missense_variant | 4/5 | 5 | |||
PEX11G | ENST00000599519.1 | n.281C>T | non_coding_transcript_exon_variant | 3/4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000820 AC: 2AN: 243928Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132666
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458566Hom.: 0 Cov.: 32 AF XY: 0.00000276 AC XY: 2AN XY: 725392
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.479C>T (p.A160V) alteration is located in exon 4 (coding exon 4) of the PEX11G gene. This alteration results from a C to T substitution at nucleotide position 479, causing the alanine (A) at amino acid position 160 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at